| 000 | 01746 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515053402.0 | ||
| 264 | 0 | _c20070917 | |
| 008 | 200709s 0 0 eng d | ||
| 022 | _a0021-972X | ||
| 024 | 7 |
_a10.1210/jc.2006-2216 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBolland, Mark J | |
| 245 | 0 | 0 |
_aAnnual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cApr 2007 |
||
| 300 |
_a1283-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 | _aBody Size |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aGrey, Andrew B | |
| 700 | 1 | _aHorne, Anne M | |
| 700 | 1 | _aBriggs, Simon E | |
| 700 | 1 | _aThomas, Mark G | |
| 700 | 1 | _aEllis-Pegler, Rod B | |
| 700 | 1 | _aWoodhouse, Andrew F | |
| 700 | 1 | _aGamble, Greg D | |
| 700 | 1 | _aReid, Ian R | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 92 _gno. 4 _gp. 1283-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2006-2216 _zAvailable from publisher's website |
| 999 |
_c16791962 _d16791962 |
||